• Study on Early vs. Delayed Ticagrelor with Cangrelor for Patients with STEMI Undergoing PCI

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on Nivolumab Dose Optimization for Patients with Melanoma or Renal Cell Carcinoma Showing Complete, Partial, or Stable Response

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study Comparing Custodiol-N and Custodiol for Heart Surgery in Children with Congenital Heart Defects

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study of Ciltacabtagene Autoleucel and Drug Combination for Treatment of High-Risk Smoldering Multiple Myeloma

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on the Effects of Bosentan on Blood Pressure in Patients with Uncontrolled Hypertension

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study Comparing Azathioprine and Methotrexate with Adalimumab for Patients with Crohn’s Disease

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Safety and Effects of SPL84 for Patients with Cystic Fibrosis

    Not yet recruiting

    2 1
    Investigated diseases:
    Czechia France Germany Hungary Italy Lithuania +4

  • Study of Nivolumab and Ipilimumab for Patients with Type B3 Thymoma and Thymic Carcinoma After Chemotherapy

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France The Netherlands Spain

  • Study on Metformin and Colchicine for Treating Long COVID Symptoms in Patients

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on the Effect of Clozapine on Immune Response in Patients with Parkinson’s Disease

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

powered by